Image via Pulse2 — funding news
Last updated
First Advantage: Product Launch
First Advantage raised full-year 2026 revenue outlook to as much as $1.71B after record Q2 results, citing strong enterprise bookings and momentum from its AI-driven technology platform
Source: Pulse2 — funding news
The leadership read
First Advantage's launch shifts talent demand before revenue catches up. In the sector, taking a release to scale rewards product leaders with a commercial edge and operators who build the post-launch motion. Watch whether First Advantage backs it with senior go-to-market hires across Americas — that separates a platform move from a one-off.
Market context: Backdrop: a 102.6 (Warm) Talent Market Index (down 1.8 on the month) with Americas activity easing (-2.2pts).
First Advantage: 1 signal in the last 90 days.
More signals across Americas
Product Launch · Americas
Oneview Healthcare →Oneview Healthcare (ASX:ONE) is launching Bedside Hub as a new product layer supporting its US growth strategy.
Product Launch · Americas
Island →Island is expanding its product portfolio into SASE (Secure Access Service Edge) and enterprise AI capabilities.
Product Launch · Americas
Wintermute →Crypto market maker Wintermute received SEC approval to trade US equities, options, and support ETF blocks. This regulatory clearance enables the firm to operate as a traditional market participant while maintaining crypto trading operations.
Product Launch · Americas
Epic Games →Epic Games is launching Fortnite Season 4 (Chapter 7: Override) on August 20, 2026, featuring expanded Sprites system with Gen 2 creatures, new Sprite Garden social experience, five community-designed Sprites, and major crossover partnerships with Sonic, Persona, Tetris, and Pac-Man.
Product Launch · Americas
DraftKings →DraftKings launched its own prediction-market platform focused on states without legalized sports betting (California, Texas, Georgia). The platform is growing faster than anticipated.
Product Launch · Americas
Elanco →Elanco's CLiK Extra (dicyclanil topical suspension) wound spray received FDA Emergency Use Authorization for prevention of New World screwworm in livestock and wildlife.
Intelligence powered by Autonodal ↗